Viemed Healthcare Reports Record 2024 Financial Results

Viemed Healthcare US ( (VMD) ) has released its Q4 earnings. Here is a breakdown of the information Viemed Healthcare US presented to its investors.

Viemed Healthcare, Inc. is a U.S.-based company specializing in in-home clinical care for post-acute respiratory healthcare, offering services such as non-invasive ventilators, sleep therapy, and other complementary products. The company has announced its record-breaking financial results for the year 2024, showcasing significant growth in revenue and patient count across its services. Viemed reported a 20% increase in net revenue for the fourth quarter of 2024, reaching $60.7 million, and a 23% increase for the full year, totaling $224.3 million. The company also achieved a net income of $11.3 million for the year, marking its eighth consecutive year of positive net income. Viemed’s patient count for ventilator and PAP therapy saw substantial growth, with increases of 14% and 43% respectively. The company’s adjusted EBITDA reached a record $51.1 million for the year, reflecting strong operational performance. Looking ahead, Viemed anticipates continued growth in 2025, with projected net revenue between $254 million and $265 million, and adjusted EBITDA between $54 million and $58 million. The company plans to expand its sales force and leverage its established payer relationships to explore new opportunities and potentially pursue inorganic growth.